Ocular Therapeutix's market cap is currently $1.14B. The company's EPS TTM is $-1.319; its P/E ratio is ―; Ocular Therapeutix is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 58.44M	$ 51.49M	$ 43.52M	$ 17.40M	$ 4.23M
Gross Profit	$ 53.16M	$ 46.95M	$ 39.12M	$ 15.32M	$ 1.90M
Operating Income	$ -82.38M	$ -78.65M	$ -78.04M	$ -62.85M	$ -85.80M
EBITDA	$ -66.42M	$ -61.91M	$ -75.62M	$ -146.09M	$ -77.74M
Net Income	$ -80.74M	$ -63.42M	$ -10.80M	$ -159.63M	$ -89.94M
Balance Sheet
Cash & Short-Term Investments	$ 195.81M	$ 102.30M	$ 164.16M	$ 228.06M	$ 54.44M
Total Assets	$ 252.06M	$ 149.29M	$ 204.89M	$ 261.86M	$ 78.74M
Total Debt	$ 83.39M	$ 64.28M	$ 58.98M	$ 58.44M	$ 59.34M
Net Debt	$ -112.42M	$ -38.02M	$ -105.18M	$ -169.62M	$ 4.91M
Total Liabilities	$ 160.93M	$ 113.91M	$ 116.89M	$ 185.77M	$ 82.37M
Stockholders' Equity	$ 91.13M	$ 35.38M	$ 88.00M	$ 76.09M	$ -3.63M
Cash Flow
Free Cash Flow	$ -76.32M	$ -63.32M	$ -66.74M	$ -54.40M	$ -79.82M
Operating Cash Flow	$ -70.23M	$ -59.60M	$ -65.55M	$ -53.55M	$ -77.58M
Investing Cash Flow	$ -6.09M	$ -3.71M	$ -1.19M	$ -841.00K	$ -2.24M
Financing Cash Flow	$ 169.83M	$ 1.45M	$ 2.85M	$ 228.01M	$ 75.34M

Currency in USD

Ocular Therapeutix Earnings and Revenue History

Income Statement >

Ocular Therapeutix Debt to Assets

Balance Sheet >

Ocular Therapeutix Cash Flow

Cash Flow >

Ocular Therapeutix Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing